Methylmalonic semialdehyde dehydrogenase deficiency: Psychomotor delay and methylmalonic aciduria without metabolic decompensation

Charles R. Roe, Eduard Struys, Robert M. Kok, Diane S. Roe, Robert A. Harris, Cornelis Jakobs

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

A patient presenting with developmental delay but no episodes of metabolic acidosis was found to excrete significant amounts of methylmalonate (MMA) without any associated increased excretion of malonate, ethylmalonate, 3-hydroxypropionate, or β-alanine. In contrast to patients with methylmalonic aciduria due to deficient mutase or impaired cobalamin metabolism, there was no increase of propionylcarnitine in blood or urine. The activity of methylmalonylCoA mutase and the pathway for cobalamin metabolism were also intact. The quantitative levels of the various labeled enantiomers of 3-hydroxyisobutyric (3-HIBA), 3-aminoisobutyric (3-AIBA), MMA, and propionylcarnitine were compared following separate intravenous infusions of equimolar doses of [2H8]valine or [2H4]thymine in this patient and another with methylmalonyl-CoA mutase deficiency. Levels of labeled S- and R- 3-HIBA and S- and R-3-AIBA indicated an isolated defect in methylmalonic semialdehyde dehydrogenase in this patient. This condition can be recognized by plasma MMA levels of ~8.5 μM (cf. 400 μM in mutase deficiency), urine MMA of 20-55 μmol/kg/24 h (cf. 1150 μmol/kg/24 h), no increase in propionylcarnitine following an oral carnitine load, and increased excretion of S-3-AIBA-nearly 10 times that observed in mutase deficiency. The ratio of RAIBA to S-AIBA of < 1 also reflects this disorder.

Original languageEnglish (US)
Pages (from-to)35-43
Number of pages9
JournalMolecular Genetics and Metabolism
Volume65
Issue number1
DOIs
StatePublished - Sep 1998

Fingerprint

propionylcarnitine
Intramolecular Transferases
Oxidoreductases
Vitamin B 12
Metabolism
Methylmalonyl-CoA Mutase
Urine
Thymine
Enantiomers
Carnitine
Valine
Acidosis
Intravenous Infusions
Alanine
Blood
Plasmas
Defects
Methylmalonic acidemia

Keywords

  • 3- aminoisobutyric
  • 3-hydroxyisobutyric
  • AIBA
  • HIBA
  • Methylmalonic
  • Methylmalonic acid
  • MMA
  • Semialdehyde
  • Thymine
  • Valine

ASJC Scopus subject areas

  • Biochemistry
  • Genetics
  • Endocrinology, Diabetes and Metabolism

Cite this

Methylmalonic semialdehyde dehydrogenase deficiency : Psychomotor delay and methylmalonic aciduria without metabolic decompensation. / Roe, Charles R.; Struys, Eduard; Kok, Robert M.; Roe, Diane S.; Harris, Robert A.; Jakobs, Cornelis.

In: Molecular Genetics and Metabolism, Vol. 65, No. 1, 09.1998, p. 35-43.

Research output: Contribution to journalArticle

Roe, Charles R. ; Struys, Eduard ; Kok, Robert M. ; Roe, Diane S. ; Harris, Robert A. ; Jakobs, Cornelis. / Methylmalonic semialdehyde dehydrogenase deficiency : Psychomotor delay and methylmalonic aciduria without metabolic decompensation. In: Molecular Genetics and Metabolism. 1998 ; Vol. 65, No. 1. pp. 35-43.
@article{572a1f69f5b845a3a06bd44cf2774f85,
title = "Methylmalonic semialdehyde dehydrogenase deficiency: Psychomotor delay and methylmalonic aciduria without metabolic decompensation",
abstract = "A patient presenting with developmental delay but no episodes of metabolic acidosis was found to excrete significant amounts of methylmalonate (MMA) without any associated increased excretion of malonate, ethylmalonate, 3-hydroxypropionate, or β-alanine. In contrast to patients with methylmalonic aciduria due to deficient mutase or impaired cobalamin metabolism, there was no increase of propionylcarnitine in blood or urine. The activity of methylmalonylCoA mutase and the pathway for cobalamin metabolism were also intact. The quantitative levels of the various labeled enantiomers of 3-hydroxyisobutyric (3-HIBA), 3-aminoisobutyric (3-AIBA), MMA, and propionylcarnitine were compared following separate intravenous infusions of equimolar doses of [2H8]valine or [2H4]thymine in this patient and another with methylmalonyl-CoA mutase deficiency. Levels of labeled S- and R- 3-HIBA and S- and R-3-AIBA indicated an isolated defect in methylmalonic semialdehyde dehydrogenase in this patient. This condition can be recognized by plasma MMA levels of ~8.5 μM (cf. 400 μM in mutase deficiency), urine MMA of 20-55 μmol/kg/24 h (cf. 1150 μmol/kg/24 h), no increase in propionylcarnitine following an oral carnitine load, and increased excretion of S-3-AIBA-nearly 10 times that observed in mutase deficiency. The ratio of RAIBA to S-AIBA of < 1 also reflects this disorder.",
keywords = "3- aminoisobutyric, 3-hydroxyisobutyric, AIBA, HIBA, Methylmalonic, Methylmalonic acid, MMA, Semialdehyde, Thymine, Valine",
author = "Roe, {Charles R.} and Eduard Struys and Kok, {Robert M.} and Roe, {Diane S.} and Harris, {Robert A.} and Cornelis Jakobs",
year = "1998",
month = "9",
doi = "10.1006/mgme.1998.2737",
language = "English (US)",
volume = "65",
pages = "35--43",
journal = "Molecular Genetics and Metabolism",
issn = "1096-7192",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Methylmalonic semialdehyde dehydrogenase deficiency

T2 - Psychomotor delay and methylmalonic aciduria without metabolic decompensation

AU - Roe, Charles R.

AU - Struys, Eduard

AU - Kok, Robert M.

AU - Roe, Diane S.

AU - Harris, Robert A.

AU - Jakobs, Cornelis

PY - 1998/9

Y1 - 1998/9

N2 - A patient presenting with developmental delay but no episodes of metabolic acidosis was found to excrete significant amounts of methylmalonate (MMA) without any associated increased excretion of malonate, ethylmalonate, 3-hydroxypropionate, or β-alanine. In contrast to patients with methylmalonic aciduria due to deficient mutase or impaired cobalamin metabolism, there was no increase of propionylcarnitine in blood or urine. The activity of methylmalonylCoA mutase and the pathway for cobalamin metabolism were also intact. The quantitative levels of the various labeled enantiomers of 3-hydroxyisobutyric (3-HIBA), 3-aminoisobutyric (3-AIBA), MMA, and propionylcarnitine were compared following separate intravenous infusions of equimolar doses of [2H8]valine or [2H4]thymine in this patient and another with methylmalonyl-CoA mutase deficiency. Levels of labeled S- and R- 3-HIBA and S- and R-3-AIBA indicated an isolated defect in methylmalonic semialdehyde dehydrogenase in this patient. This condition can be recognized by plasma MMA levels of ~8.5 μM (cf. 400 μM in mutase deficiency), urine MMA of 20-55 μmol/kg/24 h (cf. 1150 μmol/kg/24 h), no increase in propionylcarnitine following an oral carnitine load, and increased excretion of S-3-AIBA-nearly 10 times that observed in mutase deficiency. The ratio of RAIBA to S-AIBA of < 1 also reflects this disorder.

AB - A patient presenting with developmental delay but no episodes of metabolic acidosis was found to excrete significant amounts of methylmalonate (MMA) without any associated increased excretion of malonate, ethylmalonate, 3-hydroxypropionate, or β-alanine. In contrast to patients with methylmalonic aciduria due to deficient mutase or impaired cobalamin metabolism, there was no increase of propionylcarnitine in blood or urine. The activity of methylmalonylCoA mutase and the pathway for cobalamin metabolism were also intact. The quantitative levels of the various labeled enantiomers of 3-hydroxyisobutyric (3-HIBA), 3-aminoisobutyric (3-AIBA), MMA, and propionylcarnitine were compared following separate intravenous infusions of equimolar doses of [2H8]valine or [2H4]thymine in this patient and another with methylmalonyl-CoA mutase deficiency. Levels of labeled S- and R- 3-HIBA and S- and R-3-AIBA indicated an isolated defect in methylmalonic semialdehyde dehydrogenase in this patient. This condition can be recognized by plasma MMA levels of ~8.5 μM (cf. 400 μM in mutase deficiency), urine MMA of 20-55 μmol/kg/24 h (cf. 1150 μmol/kg/24 h), no increase in propionylcarnitine following an oral carnitine load, and increased excretion of S-3-AIBA-nearly 10 times that observed in mutase deficiency. The ratio of RAIBA to S-AIBA of < 1 also reflects this disorder.

KW - 3- aminoisobutyric

KW - 3-hydroxyisobutyric

KW - AIBA

KW - HIBA

KW - Methylmalonic

KW - Methylmalonic acid

KW - MMA

KW - Semialdehyde

KW - Thymine

KW - Valine

UR - http://www.scopus.com/inward/record.url?scp=0031737815&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031737815&partnerID=8YFLogxK

U2 - 10.1006/mgme.1998.2737

DO - 10.1006/mgme.1998.2737

M3 - Article

C2 - 9787093

AN - SCOPUS:0031737815

VL - 65

SP - 35

EP - 43

JO - Molecular Genetics and Metabolism

JF - Molecular Genetics and Metabolism

SN - 1096-7192

IS - 1

ER -